These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 20185164
1. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter. Arcangeli A, Rocca B, Salvatori G, Ciancia M, De Cristofaro R, Antonelli M. Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164 [Abstract] [Full Text] [Related]
2. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration. Kozek-Langenecker SA, Spiss CK, Michalek-Sauberer A, Felfernig M, Zimpfer M. Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998 [Abstract] [Full Text] [Related]
3. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy. Nagarik AP, Soni SS, Adikey GK, Raman A. Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872 [Abstract] [Full Text] [Related]
4. Enoxaparin versus unfractioned heparin as anticoagulant for continuous venovenous hemodialysis: a randomized open-label trial. Garcés EO, Victorino JA, Thomé FS, Röhsig LM, Dornelles E, Louzada M, Stifft J, de Holanda F, Veronese FV. Ren Fail; 2010 Jan; 32(3):320-7. PubMed ID: 20370447 [Abstract] [Full Text] [Related]
5. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding. Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A. J Nephrol; 2003 Jan; 16(4):566-71. PubMed ID: 14696760 [Abstract] [Full Text] [Related]
14. Attenuation of platelet reactivity by enoxaparin compared with unfractionated heparin in patients undergoing haemodialysis. Aggarwal A, Whitaker DA, Rimmer JM, Solomon RJ, Gennari FJ, Sobel BE, Schneider DJ. Nephrol Dial Transplant; 2004 Jun 15; 19(6):1559-63. PubMed ID: 15034156 [Abstract] [Full Text] [Related]
15. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis. Gainza FJ, Quintanilla N, Pijoan JI, Delgado S, Urbizu JM, Lampreabe I. J Nephrol; 2006 Jun 15; 19(5):648-55. PubMed ID: 17136695 [Abstract] [Full Text] [Related]
16. Continuous venovenous hemodiafiltration versus hemodialysis as renal replacement therapy in patients with acute renal failure in the intensive care unit. Chang JW, Yang WS, Seo JW, Lee JS, Lee SK, Park SK. Scand J Urol Nephrol; 2004 Jun 15; 38(5):417-21. PubMed ID: 15764254 [Abstract] [Full Text] [Related]
17. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis. de Pont AC, Bouman CS, Bakhtiari K, Schaap MC, Nieuwland R, Sturk A, Hutten BA, de Jonge E, Vroom MB, Meijers JC, Büller HR. ASAIO J; 2006 Jun 15; 52(4):416-22. PubMed ID: 16883122 [Abstract] [Full Text] [Related]
18. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system. Tan HK, Yang WS, Chow P, Lui HF, Choong HL, Wong KS. Artif Organs; 2007 Mar 15; 31(3):193-9. PubMed ID: 17343694 [Abstract] [Full Text] [Related]